Clinical Study on the Efficacy and Continuous Docetaxel Based Chemotherapy Treatment for Castration-Resistant Prostate Cancer

We report a retrospective study on the efficacy, adverse events and the factors for continuous docetaxel (DOC) therapy for patients with castration-resistant prostate cancer (CRPC). Between April 2007 and April 2015, 37 CRPC patients were treated with DOC therapy at Kanazawa Medical University Hospi...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 63(2017), 9 vom: 09. Sept., Seite 351-357
1. Verfasser: Chikazawa, Ippei (VerfasserIn)
Weitere Verfasser: Inoue, Shinya, Nakazawa, Yusuke, Nakai, Dan, Morita, Nobuyo, Tanaka, Tatsuro, Motoo, Yoshiharu, Miyazawa, Katsuhito
Format: Online-Aufsatz
Sprache:Japanese
Veröffentlicht: 2017
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article Castration resistant prostate cancer Docetaxel Antineoplastic Agents Taxoids 15H5577CQD